High rates of 30-day mortality in patients with cirrhosis and COVID-19Massimo Iavarone, Pietro Lampertico, Roberta D’Ambrosio et al.|Journal of Hepatology|2020Cited by 392
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange ProgramM. John Gill, J. Gasnault, I. W. Husstedt et al.|Clinical Infectious Diseases|2012Cited by 208
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Journal of Hepatology|2018Cited by 132
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*Jennifer Tom, Fang Cai, Min Bao et al.|Critical Care Medicine|2021Cited by 42